Cargando…
Cell-based Immunotherapy for Colorectal Cancer with Cytokine-induced Killer Cells
Colorectal cancer is the third leading cancer worldwide. Although incidence and mortality of colorectal cancer are gradually decreasing in the US, patients with metastatic colorectal cancer have poor prognosis with an estimated 5-year survival rate of less than 10%. Over the past decade, advances in...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Association of Immunologists
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853502/ https://www.ncbi.nlm.nih.gov/pubmed/27162526 http://dx.doi.org/10.4110/in.2016.16.2.99 |